Spermosens Financial Statements From 2010 to 2026

9R5 Stock   0  0.0002  14.29%   
Spermosens' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Spermosens' valuation are provided below:
Market Capitalization
634.6 K
There are over thirty-nine available fundamental trend indicators for Spermosens AB, which can be analyzed over time and compared to other ratios. Active traders should verify all of Spermosens AB current fundamental drivers against the trend between 2010 and 2026 to make sure the company can sustain itself down the road.
Check Spermosens financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Spermosens' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Expense of 762 K or Selling General Administrative of 4.8 M, as well as many indicators such as . Spermosens financial statements analysis is a perfect complement when working with Spermosens Valuation or Volatility modules.
  
This module can also supplement various Spermosens Technical models . Check out the analysis of Spermosens Correlation against competitors.

Spermosens Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets25.4 M35.7 M25.7 M
Very volatile
Other Current Liabilities674.9 K765.9 K333.3 K
Slightly volatile
Total Current Liabilities5.8 M4.3 M2.9 M
Slightly volatile
Total Stockholder Equity19.1 M31.4 M22.4 M
Pretty Stable
Accounts Payable1.3 M2.3 M788.1 K
Slightly volatile
Cash563.4 K593.1 K5.1 M
Slightly volatile
Non Current Assets Total21 M33.7 M19.5 M
Slightly volatile
Common Stock Shares Outstanding915 M871.5 M225.6 M
Slightly volatile
Total Liabilities6.3 M4.3 M3.3 M
Slightly volatile
Net Invested Capital22.3 M31.7 M23.6 M
Very volatile
Short and Long Term Debt251.3 K264.5 K685.8 K
Slightly volatile
Total Current Assets1.5 M1.6 M5.9 M
Slightly volatile
Capital Stock2.4 M2.8 M1.5 M
Slightly volatile
Intangible Assets19.2 M28 M18.7 M
Pretty Stable
Net Debt3.2 M5.8 M1.7 M
Slightly volatile
Non Currrent Assets Other3.6 MM4.4 M
Slightly volatile

Spermosens Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Expense762 K1.2 M454.2 K
Slightly volatile
Selling General Administrative4.8 M3.7 M6.1 M
Slightly volatile
Gross Profit619 K651.6 K2.8 M
Slightly volatile
Total Operating Expenses12.5 M10.5 MM
Slightly volatile
Research Development5.9 M4.7 M10.1 M
Slightly volatile

Spermosens Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Change In Working CapitalM2.9 M1.2 M
Slightly volatile
Begin Period Cash Flow3.1 MM3.7 M
Very volatile
Capital Expenditures7.4 M4.1 M11.3 M
Slightly volatile
Issuance Of Capital Stock14.7 M8.2 M22.9 M
Slightly volatile
End Period Cash Flow563.4 K593.1 K5.1 M
Slightly volatile

About Spermosens Financial Statements

Spermosens stakeholders use historical fundamental indicators, such as Spermosens' revenue or net income, to determine how well the company is positioned to perform in the future. Although Spermosens investors may analyze each financial statement separately, they are all interrelated. For example, changes in Spermosens' assets and liabilities are reflected in the revenues and expenses on Spermosens' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Spermosens AB. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of Revenue-832.6 K-874.2 K

Currently Active Assets on Macroaxis

Other Information on Investing in Spermosens Stock

Spermosens financial ratios help investors to determine whether Spermosens Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Spermosens with respect to the benefits of owning Spermosens security.